Hearing the inside story and understanding the team behind the performance is crucial to making informed decisions. Join us at our next Proactive event to see leading growth companies make their pitch
At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets. Affimer proteins...
ReNeuron is a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines.
Join our audience of astute high net worth investors, fund managers, private client brokers and analysts
Look beyond the numbers and meet the people creating the value for shareholders
Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
Stay and network over refreshments
One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.